Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 29, 2025 08:56 ET | Source: Research and Markets

Allergy Treatment Global Forecast Report 2025: Market to Grow by Over $20 Billion by 2033, Driven by by Accelerated Illness Prevalence, Climate-driven Allergy Amplification, and Innovative Biologics

Dublin, Sept. 29, 2025 (GLOBE NEWSWIRE) -- The "Allergy Treatment Global Market Report by Type, Treatment, Dosage Form, Distribution Channel, Countries and Company Analysis, 2025-2033" report has...
September 29, 2025 04:04 ET | Source: Research and Markets

Systemic Mastocytosis Market Analysis and Forecast, 2025-2035 | Precision Medicine Gains Momentum as KIT D816V Mutation Detection Advances

Dublin, Sept. 29, 2025 (GLOBE NEWSWIRE) -- The "Systemic Mastocytosis Market - A Global and Regional Analysis: Focus on Country and Region - Analysis and Forecast, 2025-2035" report has been added...
September 10, 2025 11:46 ET | Source: Asthma and Allergy Foundation of America

AAFA Bill to Require Allergen Labeling in Restaurants Passes in California

Washington, DC, Sept. 10, 2025 (GLOBE NEWSWIRE) -- The Asthma and Allergy Foundation of America (AAFA) issued the following statement on news that the California Assembly and Senate passed SB 68 –...
September 08, 2025 06:30 ET | Source: Regeneron Pharmaceuticals, Inc.

Regeneron Advances Allergy Pipeline with Two Positive Phase 3 Trials Evaluating First-in-Class Antibody-Blockers of Cat and Birch Allergies

In separate cat and birch allergen-challenge trials, single doses of allergen-specific antibody blockers significantly reduced allergy symptoms compared to placebo Data from these trials will support...
August 15, 2025 03:00 ET | Source: European Academy of Allergy and Clinical Immunology

EAACI Launches Global Antibiotic Allergy Awareness Campaign at EAACI Congress 2025

ZURICH, Aug. 15, 2025 (GLOBE NEWSWIRE) -- EAACI has launched its Antibiotic Allergy Awareness Campaign during its 2025 Congress in Glasgow. The initiative begins a global effort to address...
July 21, 2025 06:25 ET | Source: ALK Abello

ALK’s tree pollen tablet (ITULAZAX®) now recommended by NICE for use in the UK health system

ALK (ALKB:DC / OMX: ALK B) today announced that the National Institute for Health and Care Excellence (NICE) has recommended the use of the company’s tree pollen tablet ITULAZAX® for the treatment in...
July 18, 2025 08:01 ET | Source: ALK Abello

EURneffy® godkendt som den første nålefri behandling af anafylaksi hos voksne og børn i Storbritannien

Intern viden ALK (ALKB:DC / OMX: ALK B) har i dag annonceret, at det britiske Medicines and Healthcare Products Regulatory Agency (MHRA) har godkendt EURneffy® 2 mg til behandling af anafylaksi hos...
July 18, 2025 08:01 ET | Source: ALK Abello

EURneffy® approved as the first needle-free anaphylaxis treatment of adults and children in the UK

Inside Information ALK (ALKB:DC / OMX: ALK B) today announced that the Medicines and Healthcare Products Regulatory Agency (MHRA) has approved EURneffy® 2 mg in the United Kingdom (UK) for...
July 17, 2025 03:00 ET | Source: European Academy of Allergy and Clinical Immunology

La dirección de la EAACI reflexiona sobre el Congreso 2025, que batió récords: momento crucial para la alergia y la inmunología

ZÚRICH, July 17, 2025 (GLOBE NEWSWIRE) -- El Congreso EAACI 2025 contó con la asistencia de más de 7600 delegados y fue noticia no solo por su magnitud, sino por el poderoso mensaje que...
July 17, 2025 03:00 ET | Source: European Academy of Allergy and Clinical Immunology

הנהגת EAACI דנה בקונגרס שובר השיאים 2025: רגע מכריע לנושאי אלרגיה ואימונולוגיה

ציריך, July 17, 2025 (GLOBE NEWSWIRE) -- עם למעלה מ-7,600 נציגים, כנס EAACI 2025 עלה לכותרות לא רק בגלל היקפו אלא בגלל המסר העוצמתי שהעבירו המארגנים שלו. כעת, חודש לאחר סיום הקונגרס בגלזגו, הדמויות...